Drug Shortage Report for NOVAMOXIN
Report ID | 169966 |
Drug Identification Number | 00452130 |
Brand name | NOVAMOXIN |
Common or Proper name | TEVA-AMOXICILLIN SUS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | AMOXICILLIN |
Strength(s) | 250MG |
Dosage form(s) | GRANULES FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100,150 |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-22 |
Estimated end date | 2023-07-10 |
Actual end date | 2023-07-04 |
Shortage status | Resolved |
Updated date | 2024-02-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-12-01 | French | Compare |
v11 | 2022-12-01 | English | Compare |
v10 | 2022-11-18 | English | Compare |
v9 | 2022-11-14 | French | Compare |
v8 | 2022-11-14 | English | Compare |
v7 | 2022-10-28 | French | Compare |
v6 | 2022-10-28 | English | Compare |
v5 | 2022-09-30 | French | Compare |
v4 | 2022-09-30 | English | Compare |
v3 | 2022-09-23 | English | Compare |
v2 | 2022-09-22 | French | Compare |
v1 | 2022-09-22 | English | Compare |